bupropion has been researched along with raclopride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ahmad, R; Egerton, A; Grasby, PM; Hirani, E; Howes, OD; Lappin, JM; Mehta, MA; Reeves, SJ; Shotbolt, JP; Stokes, PR | 1 |
| Abrams, AL; Allen-Martinez, Z; Brody, AL; Costello, MR; Farahi, J; London, ED; Mandelkern, MA; Olmstead, RE; Scheibal, D; Shoptaw, S; Shulenberger, S | 1 |
| Elias, D; Gutierrez, R; Kalyanasundar, B; Luna, A; Moreno, MG; Perez, CI; Simon, SA; Solorio, J | 1 |
| Bocher, M; Chisin, R; Freedman, N; Greif, J; London, E; Mishani, E; Weinstein, AM; Yemini, Z | 1 |
1 trial(s) available for bupropion and raclopride
| Article | Year |
|---|---|
Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.
Topics: Adult; Aged; Analysis of Variance; Bupropion; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Raclopride; Smoking; Statistics as Topic; Synapses; Tobacco Use Disorder; Young Adult | 2010 |
4 other study(ies) available for bupropion and raclopride
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study.
Topics: Adult; Animals; Bupropion; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Raclopride; Rats; Rats, Sprague-Dawley | 2010 |
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
Topics: Action Potentials; Animals; Appetite Depressants; Benzazepines; Bupropion; Diethylpropion; Dopamine D2 Receptor Antagonists; Drug Interactions; Eating; Locomotion; Male; Nucleus Accumbens; Phentermine; Raclopride; Random Allocation; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sleep Initiation and Maintenance Disorders; Stereotyped Behavior; Weight Loss | 2015 |
Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment.
Topics: Adult; Brain; Bupropion; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Smoking; Smoking Cessation; Statistics as Topic; Tobacco Use Disorder | 2016 |